Get In Touch

Amebicide is a type of anti-infective drug. Amebicides are agents that kill or destroy amebae. Every amebicide has a different mode of action. Amebicides are used for the eradication of parasitic species of amebae in humans or animals. Amebicides are used for the treatment of various infectious diseases such as amebiasis. Amebiasis is an infection that is caused by Entamoeba histolytica. Entamoeba histolytica infects the intestinal tract of humans or animals. Amebicide drugs are given orally or intravenously. The absorption of an amebicide drug is complete and rapid. Due to rapid absorption through the gastrointestinal tract, these drugs are less effective against parasites in the lumen. Amebicide drugs are distributed to all tissues and body fluids such as the milk, the saliva, and the cerebrospinal fluid. An amebicide drug is metabolized by oxidation in the liver by mixed function oxidase, followed by glucouronylation. The drug is excreted in the urine as an unchanged drug and metabolite. Amebicide drugs can cause certain adverse effects such as oral thrush, diarrhea, metallic taste, dry mouth, vomiting, or nausea.

Increasing prevalence of parasitic infections all over the world drives the global amebicide drugs market. The increasing pool of patients suffering from amebic infections and high cost of new drugs are likely to boost this market remarkably in the next few years. The rising level of awareness, better treatment facilities, continued launch of effective drugs, and presence of favorable reimbursement policies for high-cost treatments are expected to drive the global amebicide drugs market during the forecast period. The geriatric population is more prone to infections due to their low immunity levels. Infections, especially parasitic, are becoming increasingly common among the elderly people.

The global amebicide drugs market can be categorized based on product, infection type, site of action, mechanism of action, distribution channel, and region. Based on product, the market can be classified into branded drugs and generic drugs. In terms of infection type, the amebicide drugs market can be categorized into bone infection, skin infection, ENT infections, gastrointestinal infection, surgical site infections, bloodstream infections, ventilator-associated pneumonia, and urinary tract infections. Based on site of action, the market can be segmented into luminal amebicides, systemic amebicides, and mixed (luminal and systemic) amebicides. Based on mechanism of action, the amebicide drugs market can be categorized into inactivation of enzymes, inhibition of protein synthesis, and inhibition of DNA replication. In terms of distribution channel, the market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies.

Geographically, the amebicide drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016, due to presence of a large number of multi-drug-resistant ameba and high prevalence of various infections among people in the region. This region also has large geriatric population, which is more prone to different infections led by lowered level of immunity. Hence, the elderly people require use of various amebicide drugs. This, in turn, promotes growth of the amebicide drugs market in North America. Europe held the second-largest market share in 2016, due to technological advancements and increase in research and development activities in the region. The amebicide drugs market in Asia Pacific is likely to expand rapidly during the forecast period. Growth of the market in the region is attributable to developing infrastructure, growing awareness, and increasing purchasing power of people in the region. The market in Middle East & Africa and Latin America is anticipated to expand during the forecast period, due to increasing prevalence of parasitic infections in these regions.

Key players operating in the global amebicide drugs market include Romark, L.C., Sanofi, Presutti Laboratories, LLC, and Heritage Pharmaceuticals.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Amebicide Drugs Market

Pre Book